Mr. Brad Sorenson at the Industry, Science and Technology Committee

On February 16th, 2021. See this statement in context.

February 16th, 2021 / 12:35 p.m.

Chief Executive Officer, Providence Therapeutics

Certainly.

We designed the vaccine. We took that vaccine into animal trials where we tested safety and we tested efficacy. We did two efficacy trials: one in mice and one in hamsters. We did a number of safety trials.

See context to find out what was said next.